resveratrol has been researched along with Dilatation, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Vries, CJ; de Waard, V; Franken, R; Groenink, M; Gunst, Q; Hibender, S; Lutgens, E; Mulder, BJ; Pinto, YM; Schermer, EE; Ter Braake, A; van den Hoff, MJ; van der Made, I; van Roomen, C; Zwinderman, AH | 1 |
Choi, BI; Hwang, SY; Jang, JY; Jeon, JH; Joo, SS; Kim, YB; Nahm, SS; Park, D; Shin, S | 1 |
2 other study(ies) available for resveratrol and Dilatation, Pathologic
Article | Year |
---|---|
Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
Topics: Active Transport, Cell Nucleus; Animals; Aorta; Aortic Aneurysm; Apoptosis; Cells, Cultured; Cellular Senescence; Dilatation, Pathologic; Disease Models, Animal; Elastin; Female; Fibrillin-1; Genetic Predisposition to Disease; Human Umbilical Vein Endothelial Cells; Humans; Male; Marfan Syndrome; Mice, Inbred C57BL; Mice, Mutant Strains; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Sirtuin 1; Stilbenes | 2016 |
Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Cleft Palate; Dilatation, Pathologic; Female; Hydronephrosis; Male; Mice; Mice, Inbred C57BL; Polychlorinated Dibenzodioxins; Pregnancy; Receptors, Aryl Hydrocarbon; Resveratrol; Severity of Illness Index; Stilbenes; Teratogens | 2008 |